Cohance Lifesciences Ltd (COHANCE) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1003386, "name": "Cohance Life", "stock_name": "Cohance Life", "full_name": "Cohance Lifesciences Ltd", "name_url": "stocks-analysis/cohance-life", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "480.95", "chg": 26.35, "chgp": "5.8%", "dir": 1, "prev_price": "454.60", "mcapval": "18,665.00 Cr", "mcap": "Small Cap", "scripcode": 543064, "symbol": "COHANCE", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE03QK01018", "curr_date": "May 06", "curr_time": "", "bse_nse_vol": "1.51 cr", "exc_status": "Active", "traded_date": "May 06, 2026", "traded_date_str": "2026 05 06", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/cohance-life-1003386-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Cohance Lifesciences Ltd Sees Surge in Value Trading Amid Sector Outperformance", "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-ltd-sees-surge-in-value-trading-amid-sector-outperformance-3977434", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/CohanceLifescie_most_active_equities_by_value_3977434.png", "date": "2026-05-06 10:00:27", "description": "Cohance Lifesciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a significant surge in trading activity on 6 May 2026, driven by high-value turnover and notable institutional interest. The stock outperformed its sector and broader market indices, signalling renewed investor confidence despite a recent downgrade in its mojo grade." }, { "title": "Cohance Lifesciences Ltd Surges 8.78% to Day's High of Rs 498.05 — Outperforms Sector by 8.05 Percentage Points", "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-ltd-hits-intraday-high-with-strong-878-surge-3977263", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/CohanceLifescie_priceRelatedfactors_3977263.png", "date": "2026-05-06 09:31:11", "description": "The Sensex gained a modest 0.52% on 6 May 2026, while Cohance Lifesciences Ltd surged 8.78%, reaching an intraday high of Rs 498.05. This 8.05-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers highlights a distinctly stock-specific rally rather than a broad market lift." }, { "title": "Cohance Lifesciences Ltd Valuation Shifts Signal Price Attractiveness Challenges", "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-ltd-valuation-shifts-signal-price-attractiveness-challenges-3976748", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/CohanceLifescie_valuationdot_3976748.png", "date": "2026-05-06 08:00:55", "description": "Cohance Lifesciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation parameters shift notably, prompting a reassessment of its price attractiveness. Despite a recent downgrade in its Mojo Grade from Strong Sell to Sell, the stock’s elevated price-to-earnings (P/E) and price-to-book value (P/BV) ratios relative to peers and historical averages raise questions about its investment appeal amid volatile market returns." }, { "title": "Cohance Lifesciences Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/cohance-lifesciences-ltd-is-rated-sell-3972802", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/CohanceLifescie_mojoScore_3972802.png", "date": "2026-05-03 10:10:36", "description": "Cohance Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 Jan 2026. However, the analysis below reflects the stock's current position as of 03 May 2026, incorporating the latest fundamentals, returns, and financial metrics to provide investors with an up-to-date perspective." }, { "title": "Cohance Lifesciences Surges 33.93% in a Week: Key Drivers and Valuation Risks", "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-surges-3393-in-a-week-key-drivers-and-valuation-risks-3971469", "imagepath": "", "date": "2026-05-02 12:02:04", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>27 Apr:</strong> Upper circuit hit with 19.99% surge and record volume</p>\n <p><strong>28 Apr:</strong> Intraday high of Rs.488 and heavy institutional buying</p>\n <p><strong>29 Apr:</strong> Valuation shifts raise price risk concerns amid 14.20% gain</p>\n <p><strong>30 Apr:</strong> Moderate recovery to close at Rs.482.95 (+3.22%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.360.60</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-va..." }, { "title": "Cohance Lifesciences Ltd Valuation Shifts Signal Heightened Price Risk Amid Sector Comparisons", "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-ltd-valuation-shifts-signal-heightened-price-risk-amid-sector-comparisons-3967395", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/CohanceLifescie_valuationdot_3967395.png", "date": "2026-04-29 08:00:50", "description": "Cohance Lifesciences Ltd has witnessed a significant shift in its valuation parameters, moving from an already expensive rating to a very expensive classification. This change, coupled with a sharp 14.2% surge in its share price on 29 Apr 2026, invites a detailed analysis of its price attractiveness relative to historical levels and peer benchmarks within the Pharmaceuticals & Biotechnology sector." }, { "title": "Cohance Lifesciences Ltd Sees Exceptional Volume Surge Amidst Strong Price Rally", "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-ltd-sees-exceptional-volume-surge-amidst-strong-price-rally-3966205", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/CohanceLifescie_most_active_equities_by_volume_3966205.png", "date": "2026-04-28 10:00:17", "description": "Cohance Lifesciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, witnessed extraordinary trading volumes on 28 Apr 2026, accompanied by a robust price rally. The stock surged 16.45% intraday, significantly outperforming its sector and the broader Sensex, signalling heightened investor interest and potential accumulation." }, { "title": "Cohance Lifesciences Ltd Surges on Heavy Value Trading and Institutional Interest", "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-ltd-surges-on-heavy-value-trading-and-institutional-interest-3966213", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/CohanceLifescie_most_active_equities_by_value_3966213.png", "date": "2026-04-28 10:00:17", "description": "Cohance Lifesciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a remarkable surge in trading activity on 28 Apr 2026, driven by substantial value turnover and heightened institutional participation. The stock outperformed its sector and broader market indices, registering a robust 16.45% gain intraday amid volatile trading conditions and strong investor interest." }, { "title": "Cohance Lifesciences Ltd Surges 12.33% to Day's High of Rs 488 — Outperforms Sector by 11.57 Percentage Points", "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-ltd-hits-intraday-high-with-1233-surge-on-28-apr-2026-3966055", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/CohanceLifescie_priceRelatedfactors_3966055.png", "date": "2026-04-28 09:31:07", "description": "The Sensex edged up a marginal 0.02% after a volatile session, but Cohance Lifesciences Ltd surged 12.33% to an intraday high of Rs 488, outperforming its Pharmaceuticals & Biotechnology sector by 11.57 percentage points. This sharp single-session gain stands out amid a mixed market backdrop and raises the question of whether this is a genuine breakout or a relief rally within a broader trend." } ], "total": 555, "sid": "1003386", "stock_news_url": "https://www.marketsmojo.com/news/cohance-lifesciences-1003386" }, "announcements": [ { "caption": "Clarification On Movement In Price Of Equity Shares", "datetime": "30-Apr-2026", "details": "Clarification on Movement in Price of Equity Shares", "source": "BSE" }, { "caption": "Clarification sought from Cohance Lifesciences Ltd", "datetime": "29-Apr-2026", "details": "The Exchange has sought clarification from Cohance Lifesciences Ltd on April 29 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.<BR>", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release", "datetime": "27-Apr-2026", "details": "Press Release", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Cohance Lifesciences Ltd has declared <strong>100%</strong> dividend, ex-date: 09 Sep 22", "dt": "2022-09-09", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Cohance Lifesciences Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 25 Sep 20", "dt": "2020-09-25", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

27 Apr: Upper circuit hit with 19.99% surge and record volume

28 Apr: Intraday high of Rs.488 and heavy institutional buying

29 Apr: Valuation shifts raise price risk concerns amid 14.20% gain

30 Apr: Moderate recovery to close at Rs.482.95 (+3.22%)

Week Open

Rs.360.60

Week Close

Read full news article

Cohance Lifesciences Ltd Valuation Shifts Signal Heightened Price Risk Amid Sector Comparisons

2026-04-29 08:00:50

Cohance Lifesciences Ltd has witnessed a significant shift in its valuation parameters, moving from an already expensive rating to a very expensive classification. This change, coupled with a sharp 14.2% surge in its share price on 29 Apr 2026, invites a detailed analysis of its price attractiveness relative to historical levels and peer benchmarks within the Pharmaceuticals & Biotechnology sector.

Read full news article

Cohance Lifesciences Ltd Sees Exceptional Volume Surge Amidst Strong Price Rally

2026-04-28 10:00:17

Cohance Lifesciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, witnessed extraordinary trading volumes on 28 Apr 2026, accompanied by a robust price rally. The stock surged 16.45% intraday, significantly outperforming its sector and the broader Sensex, signalling heightened investor interest and potential accumulation.

Read full news article

Cohance Lifesciences Ltd Surges on Heavy Value Trading and Institutional Interest

2026-04-28 10:00:17

Cohance Lifesciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a remarkable surge in trading activity on 28 Apr 2026, driven by substantial value turnover and heightened institutional participation. The stock outperformed its sector and broader market indices, registering a robust 16.45% gain intraday amid volatile trading conditions and strong investor interest.

Read full news article

Cohance Lifesciences Ltd Surges 12.33% to Day's High of Rs 488 — Outperforms Sector by 11.57 Percentage Points

2026-04-28 09:31:07

The Sensex edged up a marginal 0.02% after a volatile session, but Cohance Lifesciences Ltd surged 12.33% to an intraday high of Rs 488, outperforming its Pharmaceuticals & Biotechnology sector by 11.57 percentage points. This sharp single-session gain stands out amid a mixed market backdrop and raises the question of whether this is a genuine breakout or a relief rally within a broader trend.

Read full news article